真实世界证据分析市场规模、份额、成长分析，按组件、按应用、按收益模式、按部署模式、按地区 - 行业预测，2025-2032 年

真实世界证据分析的全球市场规模在2023 年为24 亿美元，从2024 年的25.9 亿美元增长到2032 年的48.4 亿美元，在预测期内（2025-2032 年）预计将以复合年增长率增长。

本报告分析了现实世界证据 (RWE) 分析解决方案的新兴市场，这些解决方案对于各种应用至关重要，包括报销决策、药物开发、上市后监测和临床监管流程。这些解决方案的主要最终用户包括製药、生物技术和医疗设备公司以及医疗保健付款人和提供者。 RWE 分析市场受到医疗保健巨量资料的激增、向基于价值的护理的转变以及对个人化医疗的关注的推动。随着资料复杂性和数量的增加，RWE 专案中有效的技术整合成为迫切需要。因此，许多组织正在转向云端技术，因其速度、灵活性、安全性和扩充性，以更好地保护患者资料并加速洞察生成。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术分析
• 监管分析
• 专利分析
• 案例研究

现实世界证据分析市场规模：按组成部分

• 市场概况
• 服务
• 资料
  • 临床设置资料
  • 申请资料集
  • 药房资料
  • 患者主导的资料
  • 基于註册表的资料
  • 综合资料集

真实世界证据分析市场规模：依应用分类

• 市场概况
• 药物研发及核准
  • 肿瘤学
  • 心血管疾病
  • 神经病学
  • 免疫学
  • 其他治疗领域
• 医疗设备开发及核准
• 上市后监测
• 市场进入和报销/覆盖决策
• 临床和监管决策

现实世界证据分析市场规模：依收益模式划分

• 市场概况
• 付费使用制（基于价值的定价）
• 订阅

真实世界证据分析市场规模：依部署模式

• 市场概况
• 本地
• 云端基础

真实世界证据分析市场规模：依最终用户划分

• 市场概况
• 製药和医疗设备公司
• 医疗保健付款人
• 医疗服务提供方
• 其他最终用户

现实世界证据分析市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• IQVIA Inc.（US）
• Optum, Inc.（US）
• IBM Corporation（US）
• Parexel International Corporation（US）
• Cognizant Technology Solutions Corporation（US）
• Oracle Corporation（US）
• Clinigen Group PLC（UK）
• SAS Institute Inc.（US）
• PPD, Inc.（US）
• Syneos Health, Inc.（US）
• Anthem, Inc.（US）
• Change Healthcare Inc.（US）
• Evidera, Inc.（US）
• ICON plc（Ireland）
• Flatiron Health, Inc.（US）
• HealthVerity, Inc.（US）
• Phesi Inc.（US）
• Aetion, Inc.（US）
• Medidata Solutions（US）
• Clarify Health Solutions（US）

结论和建议

Global Real World Evidence Analytics Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.59 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The report analyzes the growing market for Real-World Evidence (RWE) analytics solutions, which are essential for various applications including reimbursement decisions, drug development, post-market surveillance, and clinical regulatory processes. Key end-users of these solutions span pharmaceutical, biotechnology, medical device companies, healthcare payers, and providers. The RWE analytics market is being fueled by the surge of big data in healthcare, a shift towards value-based care, and a focus on personalized medicine. As data complexity and volume increase, there is a pressing need for effective technology integration in RWE programs. Consequently, many organizations are leveraging cloud technologies for their speed, flexibility, security, and scalability, which enhances patient data protection and accelerates insight generation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real World Evidence Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real World Evidence Analytics Market Segmental Analysis

Global Real World Evidence Analytics Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real World Evidence Analytics Market

The Global Real World Evidence Analytics market is significantly driven by the increasing elderly population, which correlates with a higher incidence of chronic diseases. This demographic trend is prompting a transition from volume-based care to value-based care models. Additionally, prolonged drug development timelines and rising costs are fueling the demand for effective RWE solutions. Moreover, enhanced research and development expenditures, alongside robust support from regulatory authorities for the adoption of real-world evidence methodologies, are further contributing to the market's expansion. Collectively, these factors are pivotal in shaping the growth trajectory of the Real World Evidence Analytics sector.

Restraints in the Global Real World Evidence Analytics Market

A major challenge facing the Global Real World Evidence Analytics market is the absence of universally accepted methodological standards and robust data processing infrastructure. This void in established guidelines for designing, conducting, analyzing, and reporting Real World Evidence (RWE) leads to skepticism about its quality and reliability. Consequently, RWE often fails to be recognized as credible enough to inform comparisons of treatment efficacy, which undermines its potential value and decreases motivation for its generation. Furthermore, this situation dissuades key stakeholders from engaging with RWE, stifling innovation and progress within the industry as a whole.

Market Trends of the Global Real World Evidence Analytics Market

The Global Real World Evidence (RWE) Analytics market is poised for significant growth as artificial intelligence (AI) becomes integral to enhancing data standards and quality control. AI applications are revolutionizing the pre-processing of real-world data (RWD), enabling pharmaceutical and biotechnology companies to accelerate insights and maximize the utility of diverse data sources. This trend is underscored by the emergence of advanced RWE technology platforms offering intelligent data processing and analysis capabilities. By leveraging AI innovations, stakeholders can improve drug research and patient outcomes while uncovering new business opportunities, ultimately fostering a more efficient and responsive healthcare ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Real World Evidence Analytics Market Size by Component & CAGR (2025-2032)

• Market Overview
• Services
• Data Sets
  • Clinical settings data sets
  • Claims data sets
  • Pharmacy data sets
  • Patient-powered data sets
  • Registry-based data sets
  • Integrated data sets

Global Real World Evidence Analytics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Other Therapeutic Areas
• Medical Device Development & Approvals
• Post-Market Surveillance
• Market Access & Reimbursement/Coverage Decision-Making
• Clinical & Regulatory Decision-Making

Global Real World Evidence Analytics Market Size by Revenue Model & CAGR (2025-2032)

• Market Overview
• Pay Per Use (Value-Based Pricing)
• Subscription

Global Real World Evidence Analytics Market Size by Deployment Mode & CAGR (2025-2032)

• Market Overview
• On-Premises
• Cloud-Based

Global Real World Evidence Analytics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users

Global Real World Evidence Analytics Market Size & CAGR (2025-2032)

• North America (Component, Application, Revenue Model, Deployment Mode, End User)
  • US
  • Canada
• Europe (Component, Application, Revenue Model, Deployment Mode, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Application, Revenue Model, Deployment Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Application, Revenue Model, Deployment Mode, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Application, Revenue Model, Deployment Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IQVIA Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant Technology Solutions Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anthem, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Change Healthcare Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evidera, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthVerity, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phesi Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aetion, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarify Health Solutions (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations